PRTN3
Basic information
Region (hg38): 19:840999-848175
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRTN3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 12 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 6 | 1 |
Variants in PRTN3
This is a list of pathogenic ClinVar variants found in the PRTN3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-841019-G-A | Likely benign (Dec 09, 2017) | |||
19-841023-C-T | Likely benign (Feb 16, 2018) | |||
19-843571-G-C | not specified | Uncertain significance (Oct 25, 2023) | ||
19-843590-G-C | not specified | Uncertain significance (Oct 27, 2021) | ||
19-843597-G-T | Benign/Likely benign (Jan 01, 2024) | |||
19-843609-G-T | Likely benign (May 18, 2018) | |||
19-843973-C-T | not specified | Uncertain significance (Oct 25, 2023) | ||
19-846150-A-G | not specified | Uncertain significance (Nov 22, 2023) | ||
19-846169-G-A | not specified | Likely benign (Jul 06, 2021) | ||
19-846246-T-G | not specified | Uncertain significance (Jul 08, 2021) | ||
19-846256-T-G | not specified | Uncertain significance (Sep 17, 2021) | ||
19-846268-A-C | not specified | Uncertain significance (Jul 06, 2021) | ||
19-846274-C-A | not specified | Uncertain significance (Jan 02, 2024) | ||
19-846298-A-G | not specified | Uncertain significance (Mar 31, 2023) | ||
19-846366-G-C | not specified | Uncertain significance (Jun 07, 2024) | ||
19-847877-C-G | not specified | Likely benign (May 05, 2023) | ||
19-847878-G-A | not specified | Uncertain significance (May 28, 2024) | ||
19-847901-C-T | not specified | Uncertain significance (Feb 17, 2024) | ||
19-847910-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
19-847944-G-A | Benign (Feb 01, 2024) | |||
19-847957-G-C | not specified | Uncertain significance (Jan 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PRTN3 | protein_coding | protein_coding | ENST00000234347 | 5 | 7213 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000380 | 0.394 | 124663 | 0 | 19 | 124682 | 0.0000762 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.153 | 140 | 145 | 0.964 | 0.00000845 | 1598 |
Missense in Polyphen | 35 | 51.675 | 0.67731 | 618 | ||
Synonymous | -0.637 | 68 | 61.6 | 1.10 | 0.00000349 | 544 |
Loss of Function | 0.233 | 7 | 7.70 | 0.909 | 4.12e-7 | 80 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000978 | 0.0000930 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000501 | 0.000375 |
European (Non-Finnish) | 0.0000606 | 0.0000533 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000705 | 0.0000328 |
Other | 0.000357 | 0.000329 |
dbNSFP
Source:
- Function
- FUNCTION: Serine protease that degrades elastin, fibronectin, laminin, vitronectin, and collagen types I, III, and IV (in vitro) (PubMed:3198760, PubMed:2033050, PubMed:28240246). By cleaving and activating receptor F2RL1/PAR-2, enhances endothelial cell barrier function and thus vascular integrity during neutrophil transendothelial migration (PubMed:23202369). May play a role in neutrophil transendothelial migration, probably when associated with CD177 (PubMed:22266279). {ECO:0000269|PubMed:2033050, ECO:0000269|PubMed:22266279, ECO:0000269|PubMed:23202369, ECO:0000269|PubMed:28240246, ECO:0000269|PubMed:3198760}.;
- Disease
- DISEASE: Note=Is the major autoantigen in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (Wegener's granulomatosis) (PubMed:2377228, PubMed:2679910). This complex, systemic disease is characterized by granulomatous inflammation with necrotizing lesions in the respiratory tract, glomerulonephritis, vasculitis, and anti-neutrophil cytoplasmatic autoantibodies detected in patient sera (PubMed:2377228, PubMed:2679910). PRTN3 causes emphysema when administered by tracheal insufflation to hamsters (PubMed:3198760). {ECO:0000269|PubMed:3198760, ECO:0000303|PubMed:2377228, ECO:0000303|PubMed:2679910}.;
- Pathway
- Neutrophil degranulation;Other interleukin signaling;Signaling by Interleukins;Cytokine Signaling in Immune system;Antimicrobial peptides;Innate Immune System;Immune System;Hemostasis;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);C-MYB transcription factor network
(Consensus)
Intolerance Scores
- loftool
- 0.378
- rvis_EVS
- 0.46
- rvis_percentile_EVS
- 78.46
Haploinsufficiency Scores
- pHI
- 0.146
- hipred
- N
- hipred_score
- 0.372
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.591
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Prtn3
- Phenotype
- hematopoietic system phenotype; immune system phenotype; cellular phenotype;
Gene ontology
- Biological process
- proteolysis;membrane protein ectodomain proteolysis;phagocytosis;blood coagulation;positive regulation of cell population proliferation;cytokine-mediated signaling pathway;antimicrobial humoral response;collagen catabolic process;neutrophil degranulation;positive regulation of GTPase activity;cell-cell junction maintenance;negative regulation of phagocytosis;neutrophil extravasation;mature conventional dendritic cell differentiation
- Cellular component
- extracellular region;extracellular space;cytosol;plasma membrane;azurophil granule lumen;plasma membrane raft;collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- serine-type endopeptidase activity;signaling receptor binding;protein binding;serine-type peptidase activity;enzyme binding